A hematologist and an oncologist with Regional Cancer Care Associates, LLC, Kenneth D. Nahum, DO, divides his time between treating patients and participating in clinical research. In addition to his involvement in clinical studies, Dr. Kenneth D. Nahum has co-written publications about different therapies for conditions like Waldenstrom’s macroglobulinemia (WM). Seen in about six people per 1 million, WM is a type of lymphoma. People who have this condition produce too much immunoglobulin M (IgM), a type of protein. As a result, the blood becomes thicker than normal and moves through the blood vessels slower. WM cells can grow in the spleen, liver, bone marrow, or lymph nodes and are easily controlled due to their slow spreading. The symptoms that appear with WM vary from person to person and may not appear for several years. Weakness is the most common symptom of WM since it results from having too few red blood cells in the body. This occurs when WM cells push out normal cells in the blood marrow. Weight loss, loss of appetite, and neuropathy, a pins-and-needles sensation in the legs, are also common for WM. Many of these symptoms are similar to certain types of non-Hodgkin lymphoma. More aggressive cases of WM are often characterized by more extreme symptoms, known as B symptoms. These include severe skin itchiness, heavy sweating, and unexplained fever.
0 Comments
A distinguished hematologist and oncologist for the past 30 years, Kenneth D. Nahum is a recipient of the Humanitarian Physician of the year award from Kimball Medical Center. Currently serving at Regional Cancer Care Associates (RCCA) in New Jersey, Kenneth D. Nahum also supports medical advancements through contributions to his local chapter of the Juvenile Diabetes Research Foundation (JDRF). One of the many ways JDRF supports patients with Type 1 diabetes (T1D) is through its artificial pancreas program. The artificial pancreas is a portable, convenient technology system that helps people managing T1D live a more normal life without the need to check blood-sugar levels or inject themselves with insulin multiple times per day. Using a continuous glucose monitor (CGM) and insulin pump, the artificial pancreas responds to changes in the patient’s blood sugar level with an algorithm-based appropriate dosage at the right time. The technology is user-friendly, miniature, and not visible to anyone other than the user. A hematologist and oncologist with Regional Cancer Care Associates (RCCA) in Howell, New Jersey, Kenneth D. Nahum has a distinguished clinical, research, and teaching career. In addition to his medical work, Kenneth D. Nahum and his wife support nonprofit and educational organizations, including the Solomon Schechter School of Monmouth County, more recently renamed the Hebrew Academy of New Jersey. To spur 21st-century learning and train students for the digital age, the Hebrew Academy features a state-of-the-art technology lab on campus. Once a basic school library and computer room, the school upgraded its technology center in 2013, equipping the space with 20 iMac computers and 30 iPad tablets. During their time in the technology lab, students learn how to perform Internet research, access learning tools available on the computers, and navigate other digitized resources. They also use learning applications and connect via video chats with other students and teachers across the globe. An oncologist and hematologist at Regional Cancer Care Associates (RCCA), Dr. Kenneth D. Nahum has been working as a physician for more than three decades. In that time, Dr. Kenneth D. Nahum has joined several professional organizations, including the American College of Physicians (ACP). The world’s largest society for internal medicine specialists and subspecialists, ACP advances the practice of internal medicine by providing professionals with a variety of education and networking opportunities. This includes the organization’s Internal Medicine Meeting, an annual conference that provides attendees with access to hands-on sessions and presentations that keep them updated on advances in their field. Designed for hospitalists, general internists, family physicians, residents, and subspecialists in internal medicine, the ACP Internal Medicine Meeting 2019 is scheduled for April 11-13 at the Pennsylvania Convention Center in Philadelphia. ACP will host more than 200 scientific sessions and offer attendees a maximum of 30.5 category 1 AMA credits. These credits can be used toward a professional’s maintenance of certification (MOC) or continuing medical education (CME) efforts. Hematologist and oncologist Dr. Kenneth D. Nahum practices with Regional Cancer Care Associates (RCCA) in New Jersey. Possessing more than 30 years of experience in medicine, Dr. Kenneth D. Nahum has treated thousands of patients and studied new treatment options for metastatic cancers. Metastasis refers to cancer that has spread from one organ to other parts of the body. This occurs when cancer cells break from the original tumor and move through the lymph system or bloodstream to new locations. Most of the time, cancers of varying types metastasize to the lungs, brain, bones, and liver. However, cancer cells can grow in other areas, including the skin, adrenal gland, and muscle. The location of metastatic cancer largely affects the symptoms a patient experiences. In certain cases, metastasis is not accompanied by any symptoms. Because of this, the condition can be difficult to diagnose if patients do not have a follow-up care plan. |
AuthorA practicing partner of Regional Cancer Care Associates, Dr. Kenneth D. Nahum, DO, has over 30 years of experience treating cancer patients in New Jersey and surrounding areas. Archives
March 2019
Categories |